These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 15069016)
21. A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Sepulveda FE; Maschalidi S; Vosshenrich CA; Garrigue A; Kurowska M; Ménasche G; Fischer A; Di Santo JP; de Saint Basile G Blood; 2015 Feb; 125(9):1427-34. PubMed ID: 25525117 [TBL] [Abstract][Full Text] [Related]
26. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707 [TBL] [Abstract][Full Text] [Related]
27. Natural Killer Cell Function Tests by Flowcytometry-Based Cytotoxicity and IFN-γ Production for the Diagnosis of Adult Hemophagocytic Lymphohistiocytosis. Lee H; Kim HS; Lee JM; Park KH; Choi AR; Yoon JH; Ryu H; Oh EJ Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671661 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases. Imashuku S; Hibi S; Sako M; Ishii T; Kohdera U; Kitazawa K; Ooe K; Naya M; Sawada H; Kawakami T J Pediatr Hematol Oncol; 1998; 20(3):207-14. PubMed ID: 9628431 [TBL] [Abstract][Full Text] [Related]
29. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice. Sepulveda FE; Garrigue A; Maschalidi S; Garfa-Traore M; Ménasché G; Fischer A; de Saint Basile G Blood; 2016 Apr; 127(17):2113-21. PubMed ID: 26864340 [TBL] [Abstract][Full Text] [Related]
30. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. Johnson TS; Terrell CE; Millen SH; Katz JD; Hildeman DA; Jordan MB J Immunol; 2014 Jan; 192(1):84-91. PubMed ID: 24259502 [TBL] [Abstract][Full Text] [Related]
31. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Sato K; Misawa N; Nie C; Satou Y; Iwakiri D; Matsuoka M; Takahashi R; Kuzushima K; Ito M; Takada K; Koyanagi Y Blood; 2011 May; 117(21):5663-73. PubMed ID: 21467545 [TBL] [Abstract][Full Text] [Related]
32. HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis. Huang R; Hayashi Y; Yan X; Bu J; Wang J; Zhang Y; Zhou Y; Tang Y; Wu L; Xu Z; Liu X; Wang Q; Zhou J; Xiao Z; Bridges JP; Marsh RA; Zhang K; Jordan MB; Li Y; Huang G Haematologica; 2017 Nov; 102(11):1956-1968. PubMed ID: 28860338 [TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis. Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Berghmans N; Boon L; Wouters C; Snoeck R; Andrei G; Matthys P Clin Exp Immunol; 2018 Apr; 192(1):104-119. PubMed ID: 29178470 [TBL] [Abstract][Full Text] [Related]
34. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032 [TBL] [Abstract][Full Text] [Related]
36. Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology. Jordan MB Immunol Rev; 2024 Mar; 322(1):339-350. PubMed ID: 38100247 [TBL] [Abstract][Full Text] [Related]
37. Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. Franco MA; Tin C; Rott LS; VanCott JL; McGhee JR; Greenberg HB J Virol; 1997 Jan; 71(1):479-86. PubMed ID: 8985374 [TBL] [Abstract][Full Text] [Related]
38. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. Dobrzanski MJ; Reome JB; Dutton RW J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. Albeituni S; Verbist KC; Tedrick PE; Tillman H; Picarsic J; Bassett R; Nichols KE Blood; 2019 Jul; 134(2):147-159. PubMed ID: 31015190 [TBL] [Abstract][Full Text] [Related]
40. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Schneider EM; Lorenz I; Müller-Rosenberger M; Steinbach G; Kron M; Janka-Schaub GE Blood; 2002 Oct; 100(8):2891-8. PubMed ID: 12351400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]